Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 27 (GPR27) is an orphan Class A (Rhodopsin-like) G protein-coupled receptor highly conserved across vertebrates and predominantly expressed in the central nervous system, particularly in brain regions such as the hippocampal dentate gyrus and hypothalamus[2][4][7][8]. GPR27 is part of the "Super conserved receptor expressed in brain" (SREB) family, including SREB1 (GPR27), SREB2 (GPR85), and SREB3 (GPR173)[2][5]. No endogenous ligands have been identified, and its precise physiological and pathological roles remain undefined. Recent evidence links GPR27 to processes such as neural plasticity, neurodevelopmental disorders, and possibly insulin secretion, but functional studies are limited[4][8]. Two selective surrogate agonists have been discovered that activate β-arrestin recruitment, but not classical G protein pathways[3]. No established drugs target GPR27, and further research is needed to clarify its disease relevance and therapeutic utility.
For surrogate agonists: β-arrestin 2 recruitment (no evidenced G protein activation for these compounds)[3]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 27 (GPR27).